跳至主要内容
临床试验/NCT05480644
NCT05480644招募中不适用

Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors

Duke University1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2022年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
1
主要终点
Number of circulating immune cells in peripheral blood

研究概览

简要总结

The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.

详细描述

Repository blood samples will be used to study the association of circulating biomarkers with radiation therapy outcomes.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have a confirmed diagnosis of primary or metastatic brain tumor (histology or imaging as appropriate)

排除标准

  • 未提供

结局指标

主要结局

Number of circulating immune cells in peripheral blood

时间窗: 6 weeks post radiation therapy

reported as mean +/- standard deviation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验